VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 134 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $206,000 | -4.2% | 10,820 | -15.0% | 0.06% | -12.5% |
| Q1 2018 | $215,000 | -4.0% | 12,730 | -13.7% | 0.07% | -1.4% |
| Q4 2017 | $224,000 | -19.7% | 14,750 | -5.2% | 0.07% | -20.7% |
| Q3 2017 | $279,000 | -46.8% | 15,560 | -51.6% | 0.09% | -38.7% |
| Q2 2017 | $524,000 | -0.9% | 32,160 | -14.9% | 0.15% | +19.0% |
| Q1 2017 | $529,000 | -12.3% | 37,800 | 0.0% | 0.13% | -8.7% |
| Q4 2016 | $603,000 | -5.9% | 37,800 | -1.9% | 0.14% | -9.2% |
| Q3 2016 | $641,000 | – | 38,540 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |